Victory Capital Management
NVO

Victory Capital Management’s Novo Nordisk NVO Stock Holding History

Victory Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Sell
25,317
-29,340
-54% -$1.26M ﹤0.01% 1820
2026
Q1 		$2.01M Sell
54,657
-129,272
-70% -$6.13M ﹤0.01% 1598
2025
Q4 		$9.36M Buy
183,929
+88,146
+92% +$4.51M 0.01% 1079
2025
Q3 		$5.31M Sell
95,783
-1,024,146
-91% -$59.9M ﹤0.01% 1322
2025
Q2 		$78M Buy
1,119,929
+1,059,179
+1,744% +$72M 0.05% 381
2025
Q1 		$4.22M Sell
60,750
-2,147
-3% -$177K ﹤0.01% 1333
2024
Q4 		$5.41M Buy
62,897
+23,223
+59% +$2.51M 0.01% 1252
2024
Q3 		$4.72M Sell
39,674
-40,682
-51% -$5.43M ﹤0.01% 1284
2024
Q2 		$11.5M Sell
80,356
-17,272
-18% -$2.29M 0.01% 1028
2024
Q1 		$12.5M Sell
97,628
-12,583
-11% -$1.5M 0.01% 993
2023
Q4 		$11.4M Sell
110,211
-64,508
-37% -$6.38M 0.01% 999
2023
Q3 		$15.9M Buy
174,719
+52,161
+43% +$4.59M 0.02% 838
2023
Q2 		$9.92M Buy
122,558
+36,198
+42% +$2.96M 0.01% 1046
2023
Q1 		$6.87M Buy
+86,360
New +$6.12M 0.01% 1139

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Victory Capital Management's NVO Position: Q2 2026 in Review

Victory Capital Management reduced its Novo Nordisk (NVO) stake by 54% in Q2 2026, selling an estimated $1.26M and leaving 25,317 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1820.

Victory Capital Management first reported a position in NVO in Q1 2023 and has held it in 14 quarters since. The position peaked at $78M in Q2 2025. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Victory Capital Management held 25,317 shares of Novo Nordisk worth $1.21M as of Q2 2026.
  • Victory Capital Management sold 29,340 Novo Nordisk shares in Q2 2026, an estimated $1.26M.
  • Novo Nordisk made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1820 holding.
  • Victory Capital Management first reported a position in Novo Nordisk in Q1 2023 and has held it in 14 quarters since.
  • Victory Capital Management's Novo Nordisk position peaked at $78M in Q2 2025.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.